Peer Review reports
From: High cumulative doxorubicin dose for advanced soft tissue sarcoma
| Original Submission | ||
|---|---|---|
| 26 Aug 2020 | Submitted | Original manuscript |
| 25 Sep 2020 | Reviewed | Reviewer Report |
| 18 Oct 2020 | Reviewed | Reviewer Report |
| 2 Nov 2020 | Author responded | Author comments - Zhichao Tian |
| Resubmission - Version 2 | ||
| 2 Nov 2020 | Submitted | Manuscript version 2 |
| 5 Nov 2020 | Reviewed | Reviewer Report |
| 8 Nov 2020 | Reviewed | Reviewer Report |
| 11 Nov 2020 | Author responded | Author comments - Zhichao Tian |
| Resubmission - Version 3 | ||
| 11 Nov 2020 | Submitted | Manuscript version 3 |
| 16 Nov 2020 | Author responded | Author comments - Zhichao Tian |
| Resubmission - Version 4 | ||
| 16 Nov 2020 | Submitted | Manuscript version 4 |
| Publishing | ||
| 18 Nov 2020 | Editorially accepted | |
| 23 Nov 2020 | Article published | 10.1186/s12885-020-07663-x |
You can find further information about peer review here.